Outlook on the KRAS Inhibitors Global Market, Drug Price, Sales, & Clinical Trials Insight to 2029
08 févr. 2023 07h38 HE
|
Research and Markets
Dublin, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The "Global KRAS Inhibitors Market, Drug Price, Sales, & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...
Patient-derived Xenograft Model Global Market Report 2022: Rising Cancer Cases and R&D by Pharmaceutical Companies Fuel Growth
28 déc. 2022 07h13 HE
|
Research and Markets
Dublin, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The "Patient-derived Xenograft Model Market Size, Share & Trends Analysis Report By Tumor Type (Lung, Pancreatic), By Model Type (Rats, Mice), By...
Global SARM1 Inhibitors Market Report 2022 to 2040 - by Target Indications, Type of Molecules, Drug Developers, Drug Candidates and Key Geographies
16 déc. 2022 07h23 HE
|
Research and Markets
Dublin, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The "SARM1 Inhibitors Market by Target Indications, Type of Molecules, Drug Developers, Drug Candidates and Key Geographies: Industry Trends and Global...
Global Artificial Intelligence for Drug Discovery and Development Market (2022 to 2027) - Featuring Cloud Pharmaceuticals, Cyclica and Deep Genomics Among Others
18 août 2022 08h03 HE
|
Research and Markets
Dublin, Aug. 18, 2022 (GLOBE NEWSWIRE) -- The "Global Artificial Intelligence for Drug Discovery and Development Market (2022-2027) by Offering, Application, End User, Technology, Geography,...
The Worldwide Combination Cancer Immunotherapy Industry is Expected to Surpass $15 Billion by 2028
23 juin 2022 06h18 HE
|
Research and Markets
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Global Combination Cancer Immunotherapy Market Opportunity and Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...
Gamma Delta T Cell Therapy Represents One of the Most Promising T Cell Therapies in Clinical Development
21 avr. 2022 07h38 HE
|
Research and Markets
Dublin, April 21, 2022 (GLOBE NEWSWIRE) -- The "Gamma Delta T Cell Cancer Therapy Market & Clinical Trials Forecast 2028" report has been added to ResearchAndMarkets.com's offering. The...
Insights on the Aptamers: Therapeutics, Technologies and Services Global Market to 2035
13 avr. 2022 07h33 HE
|
Research and Markets
Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Aptamers: Therapeutics, Technologies and Services Market" report has been added to ResearchAndMarkets.com's offering. This report features an...
US Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028: US$ 85 Billion Market Opportunity by 2028
17 mars 2022 06h58 HE
|
Research and Markets
Dublin, March 17, 2022 (GLOBE NEWSWIRE) -- The "US Cancer Antibodies Market, Drug Sales, Patent & Clinical Trials Outlook 2028" report has been added to ResearchAndMarkets.com's offering. In...
LAG 3 Inhibitor Markets, 2028
04 févr. 2022 05h53 HE
|
Research and Markets
Dublin, Feb. 04, 2022 (GLOBE NEWSWIRE) -- The "Global LAG 3 Inhibitor Clinical Trials & Market Opportunity Insight 2028" report has been added to ResearchAndMarkets.com's offering. The emerging...
Global Clinical Research Services Market Research Report (2021 to 2027) - by Services, Indication, Deployment, End-user and Region
02 févr. 2022 08h58 HE
|
Research and Markets
Dublin, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The "Clinical Research Services Market Research Report by Services, by Indication, by Deployment, by End User, by Region - Global Forecast to 2027 -...